Transdermal Delivery, Microneedles & Needle-Free Injection
Issue No #49
May 30th, 2014
Inside the magazine
Dr Richard Toon
DERMAL DELIVERY OF BIOLOGICS
Faz Chowdhury and Richard Toon describe one of the company’s key technologies for the delivery of biologics, the Micropatch™.
PATRICK ALEXANDRE, CROSSJECT
Shortly after Crossject’s successful IPO on the French NYSE Euronext Paris Exchange (Paris Bourse), Patrick Alexandre spoke about Crossject, its technology and strategy for the future as a publically traded company.
Dr Alan Smith
NOVEL TRANSDERMAL DELIVERY SYSTEMS FOR TREATMENT OF DIABETES
Alan Smith outlines the stages of Type 2 diabetes treatment, progressing to extenatide and insulin injections, and makes the case, using clinical data, for the transdermal route as a viable alternative to injections.
Bruce K Redding
TRANSDERMAL DELIVERY DEVICE DESIGN
Bruce K Redding Jnr gives an overview of the different types of transdermal patch design, as well as the various methods of getting through the skin.
Dr Kevin Pang
TRANSDERMAL DELIVERY AS A NEW SOURCE FOR BIOPHARMA INNOVATION
Kevin Pang discusses the potential of transdermal delivery, how it has thus far failed to live up to it and how a combination of formulation and electronic advancements mean it could soon be realised.
Bruce K Redding
DESIGNING AN ULTRASOUNDENABLED PATCH FOR INSULIN
Bruce K Redding Jr tells the story of the design and development of the U-Strip™ Insulin Transdermal Delivery System.
Dr Paul Vescovo
YOUR SOLUTION FOR SUCCESSFUL INTRADERMAL DELIVERY
Paul Vescovo and Laurent-Dominique Piveteau discuss the design of the Debioject™ microneedle device and inserter, and its applications, particularly in intradermal delivery of vaccines.
Dr Tim Muller
TECHNOLOGY SHOWCASE: CROSSJECT’S ZENEO
is a unique, automatic needle-free jet injector for SC, IM and ID routes, developed by Crossject. With ZENEO®, injection is fast, easy and secured.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy